nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.783	1	CbGbCtD
Bromodiphenhydramine—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.042	0.204	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0196	0.0951	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00996	0.0484	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00926	0.045	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00653	0.0318	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00597	0.029	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00597	0.029	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00453	0.022	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00453	0.022	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00421	0.0205	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00421	0.0205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00402	0.0195	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00392	0.0191	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00375	0.0182	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00372	0.0181	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00372	0.0181	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00364	0.0177	CbGpPWpGaD
Bromodiphenhydramine—Cyclopentolate—CHRM3—nephrolithiasis	0.0036	0.316	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00338	0.0164	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00332	0.0161	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00304	0.0148	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00304	0.0148	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00257	0.0125	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00235	0.0114	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00235	0.0114	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0023	0.0112	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0023	0.0112	CbGpPWpGaD
Bromodiphenhydramine—Tolterodine—CHRM3—nephrolithiasis	0.0023	0.201	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00214	0.0104	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00214	0.0104	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00191	0.00927	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00191	0.00927	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00178	0.00866	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00178	0.00866	CbGpPWpGaD
Bromodiphenhydramine—Brompheniramine—CHRM3—nephrolithiasis	0.00171	0.15	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00166	0.00805	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00166	0.00805	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00152	0.00741	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00148	0.00717	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00146	0.00712	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00146	0.00712	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00139	0.00675	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00131	0.00635	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00124	0.00603	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00119	0.0058	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00119	0.0058	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—CHRM3—nephrolithiasis	0.0011	0.0968	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.001	0.00488	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CHRM3—nephrolithiasis	0.000981	0.086	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000905	0.0044	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000905	0.0044	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000897	0.00436	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CHRM3—nephrolithiasis	0.000859	0.0753	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CHRM3—nephrolithiasis	0.000854	0.0749	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000841	0.00409	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000841	0.00409	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000775	0.00377	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00075	0.00365	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00075	0.00365	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000664	0.00323	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000599	0.00291	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000585	0.00285	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000531	0.00258	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000506	0.00246	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000463	0.00225	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000395	0.00192	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.000369	0.0018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.000359	0.00175	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000314	0.00153	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000286	0.00139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000261	0.00127	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00026	0.00126	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000237	0.00115	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000212	0.00103	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000212	0.00103	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000153	0.000746	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.00014	0.000682	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	7.04e-05	0.000342	CbGpPWpGaD
